LOUISVILLE, Ky. / Apr 05, 2023 / Business Wire / Humana Inc. (NYSE: HUM), one of the nation’s leading health and well-being companies, released its 2022 Impact Report, which highlights the company’s continued commitment to its Environmental, Social and Governance (ESG) strategy.
“At Humana, transformation toward positive health outcomes for every person we serve is something we’re passionate about,” said Bruce Broussard, Humana’s President and Chief Executive Officer. “Caring for people and making healthcare affordable, accessible and easier to navigate is at the center of all we do. We are proudly committed to transparently sharing our strategy and progress through our annual Impact Report.”
The report includes Humana’s comprehensive ESG disclosures, which are mapped to established standard frameworks related to five metrics categories: Access to Healthcare; Data Privacy & Protection; Environmental Impact; Product Quality & Safety; and Talent & Diversity. Within each category, qualitative and quantitative metrics track, measure and report our performance in achieving strategic business goals, supporting sustainable practices and improving health outcomes. The report focuses on Humana’s efforts to make quality care more equitable and accessible for employees, members and patients, communities, the healthcare system and the environment. Some of Humana’s 2022 impact highlights include:
Humana is committed to making healthcare more equitable and accessible and will continue to provide transparency in all future reporting around continued Environmental, Social and Governance practices, processes, and metrics that connect to the business strategy. Future annual impact reports and the Humana website will feature updates.
To learn more about Humana’s impact and continuing work to make it easier for people to achieve their best health, read the full 2022 Impact Report.
About Humana
Humana Inc. is committed to helping our millions of medical and specialty members achieve their best health. Our successful history in care delivery and health plan administration is helping us create a new kind of integrated care with the power to improve health and well-being and lower costs. Our efforts are leading to a better quality of life for people with Medicare, families, individuals, military service personnel, and communities at large.
To accomplish that, we support physicians and other healthcare professionals as they work to deliver the right care in the right place for their patients, our members. Our range of clinical capabilities, resources and tools – such as in-home care, behavioral health, pharmacy services, data analytics and wellness solutions – combine to produce a simplified experience that makes healthcare easier to navigate and more effective.
More information regarding Humana is available to investors via the Investor Relations page of the company’s web site at www.humana.com, including copies of:
Last Trade: | US$286.78 |
Daily Change: | 1.96 0.69 |
Daily Volume: | 1,114,639 |
Market Cap: | US$34.530B |
February 11, 2025 November 12, 2024 October 30, 2024 October 24, 2024 October 23, 2024 |
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MORETerns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MOREEnd of content
No more pages to load